|
HS Code |
248954 |
| Product Name | Alisol C Monoacetate |
| Cas Number | 18640-29-2 |
| Molecular Formula | C32H50O7 |
| Molecular Weight | 546.73 g/mol |
| Appearance | White to off-white powder |
| Solubility | Soluble in DMSO, methanol |
| Purity | Typically ≥98% |
| Storage Conditions | Store at -20°C, protected from light |
| Chemical Class | Triterpenoid |
| Source | Extracted from Alisma orientale |
| Iupac Name | Acetoxyalisol C |
| Synonyms | Alisol C monoacetate, Acetoxyalisol C |
As an accredited Alisol C Monoacetate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Alisol C Monoacetate is provided in a sealed amber glass vial containing 10 mg, with a tamper-evident screw cap and clear labeling. |
| Shipping | Alisol C Monoacetate is shipped in tightly sealed, chemical-resistant containers to ensure stability and prevent contamination. The packaging complies with relevant safety regulations for hazardous materials. During transit, temperature and humidity controls are maintained to preserve the compound’s integrity. All shipping documents include material safety data and handling instructions. |
| Storage | Alisol C Monoacetate should be stored in a tightly sealed container, in a cool, dry, and well-ventilated area, away from direct sunlight, heat, and moisture. Protect it from incompatible substances such as strong oxidizing agents. Refrigeration (2–8 °C) is recommended to maintain stability. Ensure proper labeling and store under conditions that prevent contamination and degradation. |
|
Purity 98%: Alisol C Monoacetate with 98% purity is used in pharmaceutical synthesis, where it ensures consistent bioactive compound yield. Molecular Weight 554.8 g/mol: Alisol C Monoacetate of 554.8 g/mol is used in drug formulation, where it provides precise dosage calculation and reproducibility. Melting Point 185°C: Alisol C Monoacetate with a melting point of 185°C is used in solid dispersion systems, where it supports thermal stability during processing. Particle Size <10 µm: Alisol C Monoacetate with particle size under 10 µm is used in oral tablet manufacturing, where it enhances dissolution rate and absorption. Stability Temperature 45°C: Alisol C Monoacetate stable up to 45°C is used in storage of medicinal extracts, where it maintains compound integrity under mild thermal conditions. Solubility in Ethanol 20 mg/mL: Alisol C Monoacetate with ethanol solubility of 20 mg/mL is used in liquid extract preparations, where it achieves optimal bioavailability. Residual Solvent <0.5%: Alisol C Monoacetate with residual solvent below 0.5% is used in GMP-compliant ingredient production, where it minimizes contamination risks. Optical Rotation +12°: Alisol C Monoacetate with optical rotation of +12° is used in chiral drug development, where it supports enantiomer purity control. Assay by HPLC 99%: Alisol C Monoacetate with 99% HPLC assay is used in clinical research compounds, where it guarantees high analytical accuracy. Heavy Metals <10 ppm: Alisol C Monoacetate containing less than 10 ppm heavy metals is used in dietary supplement formulations, where it ensures product safety. |
Competitive Alisol C Monoacetate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
In our own production lines, a certain sense of pride always comes through when discussing Alisol C Monoacetate. Years of seeing this compound roll out of reactors, through crystallizers, and out the door to laboratories and research centers have shaped our view of what sets it apart. This is not just another phytochemical. Here, we’re working from original raw material and a synthesis protocol we’ve tailored after repeated optimization attempts. Our assays regularly clock in at high purity, and through close monitoring of upstream processes right back to the botanical source, we maintain a consistent fingerprint batch after batch.
Alisol C Monoacetate, in our hands, means more than a name or a model on paper. We control the steps from herb extraction through each stage of purification. Our model for standard product is a crystalline powder, often supplied as a light yellow or off-white solid, and available with HPLC purity levels running typically above 98%. Over the years, multiple clients have commented on the consistent melting point range and minimal residue on ignition—a reflection of our investment in upgraded filtration and drying infrastructure.
We’ve noticed that researchers focusing on bioactive triterpenoids often circle back to our Alisol C Monoacetate when comparing lab-grade materials. Most of this focus tracks back to recent pharmacological studies showing promising anti-inflammatory and liver protective effects in preclinical models. The compound’s backbone has featured in peer-reviewed projects ranging from obesity interventions to metabolic studies. Academic groups are interested in how acetate modification at this position can amplify or shift the native activity of Alisol-family triterpenoids. Industry clients look for that same structure as a reference marker or as an input for new lead discovery programs.
A growing number of clients point out a problem seen with Alisol C acetate analogues: variability and instability during long-term storage. Our team tightened post-synthesis stabilization steps a few years ago to solve just this. Consistently low moisture content, improved container choices, and faster batch turnover times mean that fresh product reaches customers without the hydrolysis or discoloration that often creeps into older or imported stock.
Every day on the floor brings a new challenge, sometimes a lesson. Early on, we faced issues with yields thanks to fractional precipitation of co-occurring triterpenoids. A shift to closed-loop fractionation and better silica controls during purification drove up output and cut down on byproducts. Regular collaboration with analytical chemists across QC and R&D teams has permitted real-time modifications and allowed our production approach to evolve. Where competitors report structural ambiguity or mixed chromatograms, our own HPLC, NMR, and MS panels deliver clarity.
We never send out a batch unless consistency tracks with our own-house method for reference standard. Technical teams have grown used to fielding questions from purchasing agents and researchers who notice the lack of uncharacterized peaks in the analytic readout. That’s the fingerprint of genuinely controlled production, not just an afterthought bulk separation.
Sometimes product files claim uniform crystalline form for Alisol C Monoacetate, but we've seen firsthand how sources with incomplete dehydration yield amorphous or semi-hydrate forms that won’t behave the same way in downstream chemistry. At our plant, carefully staged dehydration steps create a true solid form that supports reliable solubility values in DMSO, ethanol, or methanol solvents. Watching research programs stumble over unexpected solubility or recovery issues from less stringent sources reminds us that these details are not minor.
There’s often demand from formulation labs for certain mesh sizes, and most orders from us specify a powder that can be readily measured or suspended. Lab test feedback encouraged us to rule out certain anti-caking additives which others sometimes use, creating trace byproducts that can confound sensitive assays. Choosing simple, clean preparation processes keeps chemists and biologists on track and reduces troubleshooting on their end.
Having watched plenty of supplier samples move through our hands, visible and invisible differences stand out. Some mouthpiece sources or resellers offer materials relabeled from dozens of separate micro lots or subjected to shipping conditions that break product chain-of-custody. Boxes arrive with no moisture data, unclear provenance, or even physical inconsistencies—powder shifting to lumps or showing mixed coloration. It’s impossible to replicate sensitive research outcomes using such variable material. Our Alisol C Monoacetate batches are tied to a batch record, so we know and can document every condition right from extracted herb to finished drum or vial. Cold-chain shipping for bulk and solid insulator liners for air shipments help us limit transient spikes in humidity or temperature.
Direct control of production also avoids blending or substitution events that third-party brokers are prone to, particularly during global supply disruptions. Provenance matters even more for a molecule like Alisol C Monoacetate, which often goes into research based on metabolic endpoints or cellular responses. Each batch carries ID codes from the plant floor—so researchers can trace their supply back to the actual extraction lot and purification column data.
Research results depend on having material with the same properties every time. As the manufacturer, we’re accountable for making sure every batch of Alisol C Monoacetate matches our internal reference. We keep detailed logs for every critical process parameter: solvent profiles, reaction times, temperatures, and drying cycles. Incoming quality checks on botanical material include advanced chromatography—screening out contaminants and ensuring only authenticated rhizome supplies enter the system.
We do not delegate quality control to third parties or distributors. Instead, in-house teams verify all specifications, from spectral signatures to residual solvent content. By controlling each step, we aren't surprised by shifts in mass spec readouts or inconsistencies in biological testing feedback. Clients receive a product that doesn’t just meet a checklist but reflects a repeated, verified process, which is often missing from bulk trader lots or rebottled intermediary stock.
Over the past decade, we’ve partnered directly with academic researchers and pharmaceutical teams working at the edge of triterpenoid pharmacology. They rely on a source that can supply Alisol C Monoacetate for both pilot and scale-up stages. With in-house formulation expertise, we help them translate basic findings to larger dose-response projects, even co-developing custom grades when required. Lab managers have remarked on how consistent supply and quality cut months out of their lead validation efforts.
As the original manufacturer, we have responded to direct feedback—making storage format changes, altering bulk packaging, and even advancing to GMP-aligned production protocols for select projects. We prioritize stability and traceability, especially for institutions seeking to comply with publication or clinical requirements.
Disruptions in supply, often exacerbated by pandemics or logistical shutdowns, highlight the risks of reliance on multi-tiered broker chains. Our control over everything from botanical procurement to final delivery means we can buffer clients from common shortages or delays. We forecast production based on historical demand curves, stock critical intermediates, and maintain emergency backup power and water so even regional infrastructure failures don’t ripple into months-long delays.
Responding to unpredictable global logistics requires careful attention at each step. For example, we’ve invested in smart inventory management and have designated air and sea logistics partners who understand the sensitive nature of our cargo. We use tamper-evident seals and provide real-time status updates for larger shipments. For researchers who find themselves suddenly facing grant deadlines or forced reruns due to off-spec material from other vendors, direct purchase from a manufacturer like us can make the difference between maintaining a research timeline or losing valuable project funding.
Manufacturing Alisol C Monoacetate side by side with other Alisol analogues over the years, we have developed an intimate sense of what differentiates one compound from another—chemically, physically, and as a matter of daily production reality. For example, the position and nature of acetate substitutions significantly change the behavior and biological properties of these related molecules. Our in-house analytical teams follow published QC standards, but they also perform additional routine tests to detect and prevent cross-contamination or mislabeling between similar analogues produced in adjacency.
Some suppliers aggregate multiple Alisol-family triterpenoids in partially resolved form or bulk extract, confusing research outcomes and introducing interpretive noise into biological assays. Our separate isolation lines create true mono-component product, not a spectrum triterpenoid residue. For clients analyzing bioactivity, a difference in a single substituent group in the molecule is the dividing line between activity and inactivity—or between patent novelty and infringement. The pure benchmark Alisol C Monoacetate we send out allows teams to make clear, reproducible findings.
Over nearly two decades synthesizing and supplying these triterpenoids, we’ve answered customer queries about every imaginable point of difference—be it stability under stress, reactivity with common solvents, or adverse impacts on high-precision cell models. Direct experience, built batch after batch and reinforced in everyday chemical practice, tells us there is no substitute for genuine, dedicated manufacturing.
Sometimes it's easy to forget the journey plant-derived molecules like Alisol C Monoacetate take once they leave the production plant. Our product has become a fixture in research protocols aimed at exploring new anti-inflammatory strategies, metabolic disorder models, or even screening for new bile acid pathway modulators. Its acetate modification serves as a model for investigating how small changes to a triterpenoid skeleton can impact receptor or enzyme modulation. We see citations from biomedical research centers—often with gratitude for consistent outcomes compared to prior attempts using variable crude forms.
We also support preliminary API candidate assessments by providing process analytical support and, when asked, cumulative impurity data for regulatory submission drafts. Real science rests on having exactly the right material, characterized and verified beyond a simple certificate of analysis. As a manufacturer, seeing our product referenced in published and preclinical work is a reminder of how much rides on supply and process quality. Not only bench researchers, but whole teams in lead optimization, functional screening, and formulation R&D rely on having a stable, traceable sample—reflecting exactly the botanical and chemical profile promised.
We track worldwide regulatory developments concerning plant extracts and their derivatives closely. Clients regularly request documentation to support publication, grant filing, or regulatory pre-qualification. Our traceability program has grown as a result—every outgoing batch of Alisol C Monoacetate comes with comprehensive records: identity tests, chromatographic profiles, impurity panels, and retention of reference samples for retrospective analysis.
We have participated in harmonization efforts spearheaded by pharmacopoeial societies, contributing firsthand manufacturing insight on how reference standards should be set for this compound. Questions arriving from customers about permitted solvent residues or acceptability under evolving national requirements are answered from direct production data, rather than generic industry summaries or literature projections.
Alisol C Monoacetate hasn’t just traveled through glassware and steel; it’s passed through the hands and daily routines of teams who’ve seen it from raw plant to purified batch. We constantly challenge ourselves to improve yield, remove residual solvents more thoroughly, or cut process times while maintaining analytical benchmarks. Each minor process gain, be it through better temperature ramping or a tweak in the fraction collector setup, translates into product stability and cost performance for the end user.
Remaining close to the bench and plant floor lets our team spot shifting patterns in supply, technical bottlenecks, or small process irregularities before they turn into quality deviations. Our best process enhancements often come straight from line operators who know from tactile experience how particle size or texture signals perfect crystallization—or how a faint color change tips off an unwanted side-reaction. This collective expertise shapes every outgoing batch.
Increasingly, research and industry partners come to us seeking to bypass resellers to guarantee traceable, direct-from-production supply. Explained simply, the specialization and quality possible at the manufacturing level cannot be replicated by intermediaries who purchase, relabel, or subdivide. We guarantee not only the molecular integrity of our Alisol C Monoacetate but the story of its origin, right through the specifics of crop season, plant lot, and process batch to the marked vial on a laboratory shelf.
Global demand for plant-derived pharmacological actives has only grown more competitive. Researchers and product developers turn to manufacturer-verified supplies to avoid the wasted time and expense of failed replicates, disputed patent claims, or undiagnosed product failures. Direct accountability strengthens supply relationships and brings R&D plans closer to commercial reality.
Producing a specialty triterpenoid at scale requires readiness for hurdles at every level, from variable plant yields to shifting local compliance standards. We have reorganized our production and logistics teams to anticipate and adapt to these realities. Flexible process maps, multiple validated purification trains, and rapid QC reporting cycles permit us to scale or shift production without quality tradeoff. Ongoing investment into analytics—expanded MS libraries, next-gen sequencing of source plants, and stability chamber programs for new packaging—positions us to stay ahead of market and scientific demand.
Clients raising new research or process needs spark our next iterative upgrades. Several times, specific challenges—longer-term stability for unique climates, or immediate custom powder formulations—have driven us to innovate targeted solutions based on firsthand feedback. Full control over sourcing, logistics, analysis, and production gives us the agility to respond, turning insight into on-the-ground process change and direct research support.
Alisol C Monoacetate represents more than a commodity for us. It’s a product defined through continuous hands-on engagement—refined by the needs of working researchers and mirrored in our own standards. Through controlling production, ensuring robust documentation, and enabling transparent feedback with end users, we create more than a chemical; we foster progress in pharmacological research and real translational science. For those needing a single, trusted source—and not just a brand name—our ongoing dedication to purity, stability, and practical partnership sets a standard for what Alisol C Monoacetate can mean, from field to finished workbench.